PT1009436E - Derivado de acridina para aumentar a biodisponibilidade oral do taxol - Google Patents
Derivado de acridina para aumentar a biodisponibilidade oral do taxolInfo
- Publication number
- PT1009436E PT1009436E PT98947501T PT98947501T PT1009436E PT 1009436 E PT1009436 E PT 1009436E PT 98947501 T PT98947501 T PT 98947501T PT 98947501 T PT98947501 T PT 98947501T PT 1009436 E PT1009436 E PT 1009436E
- Authority
- PT
- Portugal
- Prior art keywords
- biodisponibility
- acridine
- derived
- increase
- taxol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9718903.9A GB9718903D0 (en) | 1997-09-05 | 1997-09-05 | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1009436E true PT1009436E (pt) | 2004-03-31 |
Family
ID=10818634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98947501T PT1009436E (pt) | 1997-09-05 | 1998-09-03 | Derivado de acridina para aumentar a biodisponibilidade oral do taxol |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6469022B1 (pt) |
| EP (1) | EP1009436B1 (pt) |
| JP (2) | JP4516688B2 (pt) |
| KR (1) | KR100579030B1 (pt) |
| AT (1) | ATE253360T1 (pt) |
| AU (1) | AU751085B2 (pt) |
| BR (1) | BR9812179A (pt) |
| CA (1) | CA2302568C (pt) |
| DE (1) | DE69819525T2 (pt) |
| DK (1) | DK1009436T3 (pt) |
| ES (1) | ES2210823T3 (pt) |
| GB (1) | GB9718903D0 (pt) |
| PT (1) | PT1009436E (pt) |
| TR (1) | TR200000586T2 (pt) |
| WO (1) | WO1999012570A2 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| PL337064A1 (en) * | 1997-05-27 | 2000-07-31 | Baker Norton Pharma | Method of and compositions for orally administering taxanes to human beings |
| GB9718903D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| GB9812189D0 (en) * | 1998-06-05 | 1998-08-05 | Glaxo Group Ltd | Methods and compositions for increasing penetration of HIV protease inhibitors |
| DK1189637T3 (da) * | 1999-05-17 | 2006-12-11 | Cancer Res Ventures Ltd | Produkter til forbedring af biotilgængeligheden for oralt indgivne medikamenter |
| EP1479382A1 (en) * | 1999-06-18 | 2004-11-24 | IVAX Research, Inc. | Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same |
| BR0015149A (pt) * | 1999-10-27 | 2002-10-29 | Baker Norton Pharma | Método e composições para administração de taxanos oralmente a pacientes humanos |
| US6887842B1 (en) | 1999-11-19 | 2005-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
| CN101780092B (zh) | 2003-05-22 | 2012-07-04 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| ES2340939T3 (es) * | 2004-04-12 | 2010-06-11 | United Therapeutics Corporation | Utilizacioin del treprostinil para tratar las ulceras de pie diabeticas neuropaticas. |
| WO2006021932A1 (en) | 2004-08-27 | 2006-03-02 | Koninklijke Philips Electronics, N.V. | Electronically and remotely controlled pill and system for delivering at least one medicament |
| US20090234331A1 (en) * | 2004-11-29 | 2009-09-17 | Koninklijke Philips Electronics, N.V. | Electronically controlled pill and system having at least one sensor for delivering at least one medicament |
| WO2009104110A1 (en) * | 2008-02-18 | 2009-08-27 | Koninklijke Philips Electronics N.V. | Administration of drugs to a patient |
| EP2262413B1 (en) * | 2008-03-31 | 2014-02-26 | Medimetrics Personalized Drug Delivery B.V. | Swallowable capsule comprising a sensor and method of its preparation |
| CN102065930B (zh) | 2008-06-19 | 2013-05-22 | 皇家飞利浦电子股份有限公司 | 用于在潮湿环境下传递粉末状药物的装置 |
| RU2011102576A (ru) * | 2008-06-25 | 2012-07-27 | Конинклейке Филипс Электроникс Н.В. (Nl) | Электронная таблетка, содержащая множество емкостей с лекарственным средствами |
| WO2011018753A1 (en) | 2009-08-12 | 2011-02-17 | Koninklijke Philips Electronics N.V. | Drug delivery device with compressible drug reservoir |
| EP2970091A4 (en) | 2013-03-14 | 2017-02-08 | United Therapeutics Corporation | Solid forms of treprostinil |
| US10201552B2 (en) | 2013-09-05 | 2019-02-12 | Howard University | Method of increasing the bioavailability of an HIV drug |
| TWI838700B (zh) * | 2015-09-30 | 2024-04-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2783680B2 (ja) * | 1991-01-11 | 1998-08-06 | ラボラトワール、グラクソ、ソシエテ、アノニム | アクリジン誘導体 |
| US6245805B1 (en) | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| PL337064A1 (en) | 1997-05-27 | 2000-07-31 | Baker Norton Pharma | Method of and compositions for orally administering taxanes to human beings |
| GB9718903D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| DK1189637T3 (da) * | 1999-05-17 | 2006-12-11 | Cancer Res Ventures Ltd | Produkter til forbedring af biotilgængeligheden for oralt indgivne medikamenter |
-
1997
- 1997-09-05 GB GBGB9718903.9A patent/GB9718903D0/en active Pending
-
1998
- 1998-09-03 AU AU94394/98A patent/AU751085B2/en not_active Ceased
- 1998-09-03 TR TR2000/00586T patent/TR200000586T2/xx unknown
- 1998-09-03 AT AT98947501T patent/ATE253360T1/de active
- 1998-09-03 US US09/486,938 patent/US6469022B1/en not_active Expired - Fee Related
- 1998-09-03 PT PT98947501T patent/PT1009436E/pt unknown
- 1998-09-03 JP JP2000510467A patent/JP4516688B2/ja not_active Expired - Fee Related
- 1998-09-03 ES ES98947501T patent/ES2210823T3/es not_active Expired - Lifetime
- 1998-09-03 CA CA2302568A patent/CA2302568C/en not_active Expired - Fee Related
- 1998-09-03 DE DE69819525T patent/DE69819525T2/de not_active Expired - Lifetime
- 1998-09-03 WO PCT/EP1998/005557 patent/WO1999012570A2/en active IP Right Grant
- 1998-09-03 EP EP98947501A patent/EP1009436B1/en not_active Expired - Lifetime
- 1998-09-03 BR BR9812179-0A patent/BR9812179A/pt not_active Application Discontinuation
- 1998-09-03 KR KR1020007002323A patent/KR100579030B1/ko not_active IP Right Cessation
- 1998-09-03 DK DK98947501T patent/DK1009436T3/da active
-
2002
- 2002-09-03 US US10/233,864 patent/US6803373B2/en not_active Expired - Fee Related
-
2009
- 2009-11-10 JP JP2009257246A patent/JP2010059185A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ATE253360T1 (de) | 2003-11-15 |
| EP1009436B1 (en) | 2003-11-05 |
| US6469022B1 (en) | 2002-10-22 |
| CA2302568C (en) | 2010-06-22 |
| CA2302568A1 (en) | 1999-03-18 |
| EP1009436A2 (en) | 2000-06-21 |
| DK1009436T3 (da) | 2004-03-08 |
| ES2210823T3 (es) | 2004-07-01 |
| DE69819525T2 (de) | 2004-09-23 |
| US20030013731A1 (en) | 2003-01-16 |
| AU751085B2 (en) | 2002-08-08 |
| JP2010059185A (ja) | 2010-03-18 |
| WO1999012570A2 (en) | 1999-03-18 |
| WO1999012570A3 (en) | 1999-08-19 |
| GB9718903D0 (en) | 1997-11-12 |
| KR100579030B1 (ko) | 2006-05-12 |
| KR20010023670A (ko) | 2001-03-26 |
| US6803373B2 (en) | 2004-10-12 |
| BR9812179A (pt) | 2000-07-18 |
| DE69819525D1 (de) | 2003-12-11 |
| TR200000586T2 (tr) | 2000-09-21 |
| AU9439498A (en) | 1999-03-29 |
| JP4516688B2 (ja) | 2010-08-04 |
| JP2001515872A (ja) | 2001-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1009436E (pt) | Derivado de acridina para aumentar a biodisponibilidade oral do taxol | |
| PT1109812E (pt) | Pirrolobenzodiazepinas | |
| DZ2495A1 (fr) | Formule nouvelle de l'oméprazole-s. | |
| CY2007024I1 (el) | Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| DZ2514A1 (fr) | Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a. | |
| TR200101961T2 (tr) | 1,2-halkalı kinolin türevleri | |
| FI963169A0 (fi) | Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia | |
| NO995846L (no) | Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet | |
| ATE350036T1 (de) | Tetrahydroquinolin-derivate | |
| AR038427A2 (es) | Compuestos 15-alquil-14-hidroxilo de marcfortina y parahercuamida | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| IS2212B (is) | 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyrarramide | |
| BR9804027A (pt) | Novos beta-ceto ésteres | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
| DZ2937A1 (fr) | Compositions nouvelles de sensibilidants à l'insuline. | |
| FI962976A (fi) | Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa | |
| BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
| BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
| NO20006350D0 (no) | Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer | |
| FR2773489B1 (fr) | Nouvelle composition destinee a la voie oromuqueuse notamment pernasale | |
| NO20013715D0 (no) | Karbamatderivater av diaryl 1,3,4-oksadiazolon | |
| BR0012592A (pt) | Composto, uso dos compostos, combinação, e, preparação farmacêutica para uso oral ou parenteral | |
| IT1296403B1 (it) | Macchina per l'applicazione di silicone su calze autoreggenti. |